As either increasing total GLP1 or active GLP1 were not sufficient to protect against olanzapine induced hyperglycemia we reasoned an approach to increase endogenous GLP1 higher might confer protection against olanzapine induced increases in blood glucose. The gene discussed is GCG; the disease is Hyperglycemia.